Guggenheim Capital’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.7M Sell
205,165
-25,333
-11% -$1.83M 0.12% 170
2025
Q4
$14.7M Sell
230,498
-19,324
-8% -$1.19M 0.11% 191
2025
Q3
$15.8M Sell
249,822
-12,370
-5% -$863K 0.11% 175
2025
Q2
$19.6M Sell
262,192
-6,839
-3% -$537K 0.16% 122
2025
Q1
$23.7M Buy
269,031
+3,429
+1% +$324K 0.22% 95
2024
Q4
$24.3M Sell
265,602
-5,208
-2% -$534K 0.2% 101
2024
Q3
$30.3M Buy
270,810
+4,744
+2% +$475K 0.21% 87
2024
Q2
$26.1M Sell
266,066
-4,546
-2% -$451K 0.18% 96
2024
Q1
$27.1M Sell
270,612
-6,978
-3% -$614K 0.19% 103
2023
Q4
$24.9M Sell
277,590
-4,278
-2% -$341K 0.19% 110
2023
Q3
$21.6M Sell
281,868
-10,057
-3% -$834K 0.19% 108
2023
Q2
$24.4M Buy
291,925
+3,247
+1% +$264K 0.19% 94
2023
Q1
$24.3M Buy
288,678
+44,345
+18% +$3.81M 0.2% 96
2022
Q4
$19.9M Buy
244,333
+6,420
+3% +$517K 0.17% 127
2022
Q3
$16.9M Buy
237,913
+60,496
+34% +$5.44M 0.15% 150
2022
Q2
$15.9M Buy
177,417
+12,088
+7% +$1.25M 0.13% 192
2022
Q1
$18.5M Buy
165,329
+49,370
+43% +$5.79M 0.11% 204
2021
Q4
$14M Buy
115,959
+40,916
+55% +$4.55M 0.07% 302
2021
Q3
$7.56M Buy
75,043
+17,676
+31% +$1.95M 0.05% 496
2021
Q2
$6.7M Buy
57,367
+7,573
+15% +$909K 0.04% 556
2021
Q1
$5.48M Sell
49,794
-8,204
-14% -$891K 0.04% 589
2020
Q4
$5.82M Sell
57,998
-4,494
-7% -$417K 0.04% 518
2020
Q3
$4.88M Sell
62,492
-8,100
-11% -$610K 0.04% 539
2020
Q2
$4.92M Sell
70,592
-3,361
-5% -$212K 0.04% 526
2020
Q1
$3.44M Sell
73,953
-4,000
-5% -$257K 0.03% 592
2019
Q4
$6.18M Sell
77,953
-2,230
-3% -$171K 0.05% 516
2019
Q3
$5.92M Buy
80,183
+1,676
+2% +$120K 0.05% 514
2019
Q2
$6.11M Buy
78,507
+2,000
+3% +$152K 0.05% 493
2019
Q1
$5.81M Sell
76,507
-32,328
-30% -$2.57M 0.05% 535
2018
Q4
$7.96M Sell
108,835
-25,893
-19% -$2.06M 0.07% 350
2018
Q3
$12.9M Buy
134,728
+42,142
+46% +$4.18M 0.08% 264
2018
Q2
$9.26M Sell
92,586
-364,475
-80% -$38.5M 0.06% 366
2018
Q1
$48.3M Sell
457,061
-67,945
-13% -$6.87M 0.12% 342
2017
Q4
$48.6M Buy
525,006
+16,770
+3% +$1.52M 0.12% 350
2017
Q3
$46M Sell
508,236
-4,739
-0.9% -$403K 0.11% 348
2017
Q2
$43.1M Sell
512,975
-41,609
-8% -$3.35M 0.11% 372
2017
Q1
$44.8M Buy
554,584
+55,014
+11% +$4.33M 0.12% 340
2016
Q4
$37.6M Buy
499,570
+56,855
+13% +$4.11M 0.11% 395
2016
Q3
$30M Buy
442,715
+36,727
+9% +$2.46M 0.09% 409
2016
Q2
$27.6M Buy
405,988
+59,368
+17% +$4.36M 0.09% 425
2016
Q1
$25M Sell
346,620
-11,758
-3% -$770K 0.08% 459
2015
Q4
$24.2M Buy
358,378
+16,896
+5% +$1.18M 0.07% 505
2015
Q3
$22.1M Sell
341,482
-34,831
-9% -$2.57M 0.07% 520
2015
Q2
$30.8M Sell
376,313
-60,976
-14% -$4.7M 0.08% 473
2015
Q1
$30.3M Buy
437,289
+48,493
+12% +$3.5M 0.07% 500
2014
Q4
$29.5M Sell
388,796
-96,036
-20% -$7.59M 0.07% 490
2014
Q3
$39.2M Buy
484,832
+70,515
+17% +$5.89M 0.09% 324
2014
Q2
$36.2M Buy
414,317
+41,429
+11% +$3.6M 0.09% 361
2014
Q1
$32.1M Buy
372,888
+14,491
+4% +$1.19M 0.09% 344
2013
Q4
$28.9M Buy
358,397
+22,927
+7% +$1.78M 0.09% 345
2013
Q3
$26.1M Buy
335,470
+76,285
+29% +$5.88M 0.09% 290
2013
Q2
$18.1M Buy
+259,185
New +$18.1M 0.08% 391

Other funds holding EMN

Guggenheim Capital's EMN Position: Q1 2026 in Review

Guggenheim Capital reduced its Eastman Chemical (EMN) stake by 11% in Q1 2026, selling an estimated $1.83M and leaving 205,165 shares worth $15.7M. The position accounts for 0.12% of the portfolio, ranked #170.

Guggenheim Capital first reported a position in EMN in Q2 2013 and has held it in 52 quarters since. The position peaked at $48.6M in Q4 2017. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

  • Guggenheim Capital held 205,165 shares of Eastman Chemical worth $15.7M as of Q1 2026.
  • Guggenheim Capital sold 25,333 Eastman Chemical shares in Q1 2026, an estimated $1.83M.
  • Eastman Chemical made up 0.12% of Guggenheim Capital's portfolio in Q1 2026, its #170 holding.
  • Guggenheim Capital first reported a position in Eastman Chemical in Q2 2013 and has held it in 52 quarters since.
  • Guggenheim Capital's Eastman Chemical position peaked at $48.6M in Q4 2017.
  • 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Guggenheim Capital's 13F filing for Q1 2026, filed 15 May 2026.